Sung-Sun Cho
Amministratore Delegato presso YUANTA 4 SPECIAL PURPOSE ACQUISITION CO., LTD.
Posizioni attive di Sung-Sun Cho
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| YUANTA 4 SPECIAL PURPOSE ACQUISITION CO., LTD. | Direttore/Membro del Consiglio | - | - |
| Amministratore Delegato | - | - |
Storia della carriera di Sung-Sun Cho
Precedenti posizioni note di Sung-Sun Cho
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
ProCell Therapeutics, Inc.
 ProCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ProCell Therapeutics, Inc. develops protein-based therapeutics. It handles the research and development of biotherapeutics capable of entering cells through proprietary Macromolecule Intracellcellular Transduction Technologies (MITT) using a line-up of Macromolecule Transduction Domain (MTD). The company was founded on December 12, 2005 and is headquartered in Seoul, South Korea. | Amministratore Delegato | - | - |
Statistiche
Distribuzione geografica
| Corea del Sud | 3 |
Posizioni
| Chief Executive Officer | 2 |
| Director/Board Member | 1 |
Settori
| Health Technology | 2 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| YUANTA 4 SPECIAL PURPOSE ACQUISITION CO., LTD. | Finance |
| Aziende private | 1 |
|---|---|
ProCell Therapeutics, Inc.
ProCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ProCell Therapeutics, Inc. develops protein-based therapeutics. It handles the research and development of biotherapeutics capable of entering cells through proprietary Macromolecule Intracellcellular Transduction Technologies (MITT) using a line-up of Macromolecule Transduction Domain (MTD). The company was founded on December 12, 2005 and is headquartered in Seoul, South Korea. | Health Technology |
- Borsa valori
- Insiders
- Sung-Sun Cho
- Esperienza
